Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
Chao GaoMariusz TomaniakKuniaki TakahashiHideyuki KawashimaRutao WangHironori HaraMasafumi OnoGilles MontalescotScot GargMichael HaudeTon SlagboomPascal VranckxMarco ValgimigliStephan WindeckerRobert-Jan van GeunsChristian HammPhilippe Gabriel StegYoshinobu OnumaDominick J AngiolilloPatrick W SerruysPublished in: Cardiovascular diabetology (2020)
ClinicalTrials.gov (NCT01813435).
Keyphrases
- chronic kidney disease
- end stage renal disease
- acute coronary syndrome
- phase iii
- open label
- percutaneous coronary intervention
- study protocol
- phase ii
- combination therapy
- st elevation myocardial infarction
- clinical trial
- st segment elevation myocardial infarction
- antiplatelet therapy
- peritoneal dialysis
- randomized controlled trial
- type diabetes
- metabolic syndrome
- adipose tissue
- double blind
- insulin resistance